Prevention and treatment of infectious diseases by traditional Chinese medicine: a commentary
- PMID: 31124203
- DOI: 10.1111/apm.12928
Prevention and treatment of infectious diseases by traditional Chinese medicine: a commentary
Abstract
The present review aimed to summarize the effectiveness and features of traditional Chinese medicine (TCM) for the treatment of infectious diseases and to discuss the limitation of the development of TCM. The personalized medicine with TCM exerts a curative effect on viral and bacterial infectious diseases with unique advantages on the improvement of clinical manifestation, pathogen inhibition, and organ recovery during severe and drug-resistant infection. The deficiency of personalized medicine with TCM lies in that the current research design of TCM primarily focuses on the study of the effective components and material basis of Chinese herbs at the cellular, molecular, and genetic level, while ignoring the guidance of the TCM syndrome differentiation theory, which is the core concept of individualized treatment. Personalized medicine with TCM has a broad prospective for infectious diseases due to the specific efficacy and advantages. While the curative effect of individualized treatment with TCM cannot be excluded from the TCM syndrome differentiation theory, the study of personalized medicine with TCM for infectious diseases urgently requires a unified standardization of the clinical syndrome differentiation and the evolution rule of infectious diseases by TCM theory.
Keywords: Personalized medicine; infectious disease; review; syndrome differentiation; traditional Chinese medicine.
© 2019 APMIS. Published by John Wiley & Sons Ltd.
Comment in
-
Editorial comment.APMIS. 2019 May;127(5):385. doi: 10.1111/apm.12933. APMIS. 2019. PMID: 31124202 No abstract available.
Similar articles
-
[Goal and task of integrated Chinese and Western medicine study on infectious disease].Zhongguo Zhong Xi Yi Jie He Za Zhi. 2006 Sep;26(9):842-5. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2006. PMID: 17058839 Chinese.
-
[Chinese medicine theory research on syndrome new drug development--research on intervention modes of Chinese medicine based on ancient literature].Zhongguo Zhong Yao Za Zhi. 2020 Feb;45(3):704-708. doi: 10.19540/j.cnki.cjcmm.20190606.503. Zhongguo Zhong Yao Za Zhi. 2020. PMID: 32237532 Chinese.
-
Application of Traditional Chinese Medicines as Personalized Therapy in Human Cancers.Am J Chin Med. 2018;46(5):953-970. doi: 10.1142/S0192415X18500507. Epub 2018 Jul 9. Am J Chin Med. 2018. PMID: 29986595 Review.
-
[Theoretical thinking on guiding research and development of new drugs of traditional Chinese medicine].Zhongguo Zhong Yao Za Zhi. 2021 Apr;46(7):1686-1690. doi: 10.19540/j.cnki.cjcmm.20210213.501. Zhongguo Zhong Yao Za Zhi. 2021. PMID: 33982469 Chinese.
-
Intestinal Escherichia coli and related dysfunction as potential targets of Traditional Chinese Medicine for respiratory infectious diseases.J Ethnopharmacol. 2023 Sep 15;313:116381. doi: 10.1016/j.jep.2023.116381. Epub 2023 Mar 20. J Ethnopharmacol. 2023. PMID: 36940735 Review.
Cited by
-
Phytotherapeutic potential against MRSA: mechanisms, synergy, and therapeutic prospects.Chin Med. 2024 Jun 22;19(1):89. doi: 10.1186/s13020-024-00960-8. Chin Med. 2024. PMID: 38909250 Free PMC article.
-
Introduction to Traditional Medicine and Their Role in Prevention and Treatment of Emerging and Re-Emerging Diseases.Biomolecules. 2022 Oct 9;12(10):1442. doi: 10.3390/biom12101442. Biomolecules. 2022. PMID: 36291651 Free PMC article. Review.
-
Biomedical Applications of Chinese Herb-Synthesized Silver Nanoparticles by Phytonanotechnology.Nanomaterials (Basel). 2021 Oct 18;11(10):2757. doi: 10.3390/nano11102757. Nanomaterials (Basel). 2021. PMID: 34685197 Free PMC article. Review.
-
Ulinastatin plus biapenem for severe pneumonia in the elderly and its influence on pulmonary function and inflammatory cytokines.Am J Transl Res. 2021 May 15;13(5):5027-5034. eCollection 2021. Am J Transl Res. 2021. PMID: 34150088 Free PMC article.
-
Use of traditional Chinese medicine as an adjunctive treatment for COVID-19: A systematic review and meta-analysis.Medicine (Baltimore). 2021 Jul 30;100(30):e26641. doi: 10.1097/MD.0000000000026641. Medicine (Baltimore). 2021. PMID: 34397691 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical